Common/mild side effects These are the most frequently reported reactions, often resolving within hours to a day: Injection-site pain and redness : soreness, burning, or a red patch at the needle entry point due to tissue irritation and local inflammation Headache : pressure or throbbing in the head linked to NADs effects on circulation and metabolism Nausea : queasiness or stomach upset, sometimes triggered by vagal nerve stimulation Less common/moderate side effects These occur less often but may cause discomfort or interruption of treatment: Firm lump : a knot under the skin where NAD fluid hasnt dispersed properly Sterile abscess : a noninfectious pocket of fluid or tissue breakdown at the injection site Palpitations : a sensation of a rapid, pounding, or irregular heartbeat caused by metabolic shifts Blood pressure changes : temporary rise or fall in blood pressure, sometimes with dizziness Rare/serious side effects Uncommon but important to watch for, these may require immediate medical attention: Sepsis : life-threatening whole-body infection from contaminated injection Severe local infection : painful, red, pus-filled reaction at the site, caused by bacteria Sciatic nerve injury : accidental puncture of the sciatic nerve, leading to pain, numbness, or weakness in the leg Each category deserves a closer look

Dermal fillers such as Restylane, Juvederm, and Radiesse, which are the tools of choice to enhance facial volume and fill in deep lines, can also be injected under the skin to stretch and fill out certain types of superficial and deep soft acne scars
The severity of nausea may be reduced by starting with lower doses and gradually titrating upward, eating smaller meals, avoiding high-fat foods, and maintaining adequate hydration
Your medical history, past medication experiences, and lifestyle are carefully reviewed to create a dosing plan designed specifically for you
17 A critical component of Lillys strategy is the rapid development of its oral candidate, orforglipron
Here, we show that the acute weight lossindependent actions of semaglutide to lower BP are ablated in Glp1r VSM/ mice, identifying an essential role for the VSMC GLP-1R as the BP-lowering target for semaglutide